Cerus (CERS) Debt Ratio (2010 - 2026)

Cerus (CERS) posted Debt Ratio of 0.32 for Q2 2026, down 16.87% sequentially from 0.38 in Q1 2026, and down 20.59% YoY from 0.4 in Q2 2025.

Cerus (CERS) Debt Ratio (2010 - 2026) Analysis & Trends

Cerus has reported Debt Ratio for 17 years, with the latest figure at 0.32 in Q2 2026.

Quarterly Debt Ratio fell 20.59% year-over-year to 0.32 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.32 (down 20.59% YoY) and the FY2025 annual result came in at 0.38, down 9.73% from the prior year.
Debt Ratio fell to 0.32 in Q2 2026 per CERS's latest filing, from 0.38 in the prior quarter.
Over five years, Debt Ratio peaked at 0.45 in Q2 2024 and troughed at 0.31 in Q1 2022.
A 5-year average of 0.38 and a median of 0.38 in 2023 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2024 and 2026: Debt Ratio gained 29.1% in 2024, then declined 20.59% in 2026.
Over 5 years, Debt Ratio stood at 0.32 in 2022, then rose by 26.08% to 0.4 in 2023, then gained by 3.8% to 0.42 in 2024, then dropped by 9.73% to 0.38 in 2025, then slipped by 16.33% to 0.32 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.32, 0.38, and 0.38 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	0.30
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	0.31
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	0.30
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	0.04
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	0.28
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	0.18
10	Cerus	560.58 Mn	504.32 Mn	29.53 Mn	0.32

Download Data